Strategic Acquisitions, Quarterly Financial Results and Updated Earnings Guidance - Research Report on CSC, Cerner, WebMD,

   Strategic Acquisitions, Quarterly Financial Results and Updated Earnings
  Guidance - Research Report on CSC, Cerner, WebMD, Medidata, and MedAssets

PR Newswire

NEW YORK, November 7, 2013

NEW YORK, November 7, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Computer
Sciences Corporation (NYSE: CSC), Cerner Corporation (NASDAQ: CERN), WebMD
Health Corp. (NASDAQ: WBMD), Medidata Solutions, Inc. (NASDAQ: MDSO), and
MedAssets, Inc. (NASDAQ: MDAS). Today's readers may access these reports free
of charge - including full price targets, industry analysis and analyst
ratings - via the links below.

Computer Sciences Corporation Research Report

On October 30, 2013, Computer Sciences Corporation (CSC) announced that it has
signed a definitive agreement to acquire ServiceMesh, an enterprise cloud
management company. CSC informed that the acquisition allows the Company to
continue its transformation into a next-generation IT company that helps
clients migrate their applications into cloud computing environments.
"ServiceMesh allows us to catalogue enterprise applications and orchestrate
those applications dynamically to run in different clouds based on the
characteristics of the applications. From our unique position as an
independent global technology company, we will integrate those workloads for
our clients through our portfolio of services and technologies," said Mike
Lawrie, President and CEO of CSC. "With ServiceMesh, we will empower an
ecosystem of enterprise software providers by lowering the friction for
companies to execute a multi-vendor hybrid cloud strategy while maintaining
central governance, policy and administration," added Dan Hushon, Chief
Technology Officer of CSC. The Companies expect the transaction to close in Q3
FY 2014. The Full Research Report on Computer Sciences Corporation - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:

[http://www.analystscorner.com/r/full_research_report/7438_CSC]

Cerner Corporation Research Report

On October 24, 2013, Cerner Corporation (Cerner) reported its Q3 2013
financial results. During the quarter, the Company's revenue increased 7.6%
YoY to $727.8 million. Cerner said that the revenue growth was below its
expectations due to reduced levels of low-margin technology resale. The
Company reported Q3 2013 GAAP net earnings of $115.3, or $0.33 per diluted
share, which were in line with Cerner's expectations, and higher when compared
to net earnings of $98.9 million, or $0.28 per diluted share in Q3 2012. "In
addition to our solid financial results, our third quarter included several
very strategic client wins across the globe and major development and
deployment milestones for our population health and mobility solutions," said
Neal Patterson, Chairman, CEO, and Co-founder of Cerner. "Cerner has done well
and we believe will continue to do well in the current electronic medical
record era, but it's our investments in capabilities beyond the EMR that
differentiate us from our current competitors and position us for sustained
growth through the decade." The Full Research Report on Cerner Corporation -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:

[http://www.analystscorner.com/r/full_research_report/83ac_CERN]

WebMD Health Corp. Research Report

On October 29, 2013, WebMD Health Corp. (WebMD) announced that it has acquired
Avado, Inc. (Avado), a developer of cloud-based patient relationship
management (PRM) tools and technologies that enable better communication
between consumers and health care professionals. "Our acquisition of Avado
demonstrates WebMD's commitment to playing a leading role in the emerging
patient relationship management space because we believe that connectivity has
the potential to make the delivery of care more efficient and improve patient
outcomes," said David Schlanger, CEO of WebMD. "Avado's innovative technology
and tools will complement, and further accelerate WebMD's efforts to connect
patients with their healthcare providers, which is an important first step
toward making connected care a reality," added Bill Pence, COO and Chief
Technology Officer of the Company. The Company informed that Dave Chase and
Bassam Saliba, Avado's founders, will continue with Avado and will report to
Pence. The Full Research Report on WebMD Health Corp. - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:

[http://www.analystscorner.com/r/full_research_report/c4b8_WBMD]

Medidata Solutions, Inc. Research Report

On October 24, 2013, Medidata Solutions, Inc. (Medidata) reported its Q3 2013
financial results. During the quarter, the Company's revenues increased 27.1%
YoY to $70.9 million. During the quarter, GAAP net income came in at $5.3
million, or $0.20 per diluted share, compared with $4.1 million, or $0.16 per
diluted share, in Q3 2012. "Current and new customers are increasingly
choosing to work on the Medidata Clinical Cloud to drive innovation and
improve productivity in their clinical development efforts," said Tarek
Sherif, Chairman and CEO of Medidata. "Given our strong performance year to
date, solid backlog coverage, industry leading revenue retention and a healthy
pipeline of future opportunities, we are once again raising our 2013
guidance," added Cory Douglas, CFO of the Company. For full-year 2013,
Medidata raised its guidance and now expects revenues to be in the range of
$275.3 million to $276.8 million. The Full Research Report on Medidata
Solutions, Inc. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

[http://www.analystscorner.com/r/full_research_report/05dd_MDSO]

MedAssets, Inc. Research Report

On October 30, 2013, MedAssets, Inc. (MedAssets) reported its Q3 2013
financial results. In the quarter, the Company's net revenue increased 1.8%
YoY to $166.4 million. Net income was $6.9 million, or $0.11 per diluted share
in Q3 2013, compared with $5.5 million, or $0.09 per diluted share, in Q3
2012. For full-year 2013, the MedAssets expect net revenue to be between $671
million and $677 million, representing a growth of 4.8% to 5.8% YoY. Also, the
Company expects full-year 2013 GAAP diluted EPS to be in the range of $0.39 to
$0.43. The Full Research Report on MedAssets, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

[http://www.analystscorner.com/r/full_research_report/0913_MDAS]

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to making mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

http://www.analystscorner.com/

SOURCE Analysts' Corner

Contact: Joe Thomas; +1-310-496-8071